Accelerating Discovery in the Age of a Pandemic

An expert panel will present how synthetic biology accelerates the development of diagnostics, therapeutics, and the medicinal pipeline.

Event Details:Accelerating Discovery in the Age of a PandemicDate(s):

FREE Symposium

Tuesday, February 23, 2021
1:00 - 4:00 PM, Eastern Standard Time

Register Now

Rapidly developing diagnostic tests, vaccines, and antivirals, and streamlining their production and delivery is critical to combating a pandemic. Scientists in the field of synthetic biology reengineer biological organisms and use their components to accomplish new tasks in medicine, manufacturing, agriculture, and more. With the emergence of SARS-CoV-2, synthetic biologists harnessed the diverse tools of their trade to mitigate the COVID-19 pandemic.

In this virtual symposium, brought to you by The Scientist, an expert panel will present how synthetic biology accelerates the development of diagnostics, therapeutics, and the medicinal pipeline.

Symposium program

1:10 PM – A brief message from Beckman Coulter Life Sciences
John Fuller, PhD

1:20 PM – ACE2 receptor traps potently neutralize SARS-CoV-2
Anum Glasgow, PhD

1:50 PM – De novo design of SARS-CoV-2 antivirals, diagnostics, and vaccines
David Baker, PhD

2:20 PM – Designing diagnostics ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours